Pharmaceutical Stock Bounces Off Record Lows

Kenvue Inc (NYSE:KVUE) stock is up 3.9% to trade at $17.62 at last check, erasing some of yesterday's losses that followed the Trump administration connection between the use of  acetaminophen -- the active ingredient of the company's Tylenol pain drug -- in pregnancy and autism. The link drew criticism from medical professionals, who claim it lacks scientific evidence.Though KVUE is bouncing off yesterday's record low of $16.89, it still has work to do before recouping the 7.5% bear gap. The stock is tradi ...